158 related articles for article (PubMed ID: 36001231)
1. A case of successful treatment with lenvatinib in primary hepatoid adenocarcinoma of the gallbladder that was difficult to distinguish from hepatocellular carcinoma.
Iwasaki S; Hidaka H; Uojima H; Kubo H; Adachi K; Wada N; Kubota K; Nakazawa T; Shibuya A; Kusano C
Clin J Gastroenterol; 2022 Dec; 15(6):1108-1114. PubMed ID: 36001231
[TBL] [Abstract][Full Text] [Related]
2. Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Ahn JS; Jeon JR; Yoo HS; Park TK; Park CK; Sinn DH; Paik SW
Clin Mol Hepatol; 2013 Jun; 19(2):173-8. PubMed ID: 23837142
[TBL] [Abstract][Full Text] [Related]
3. Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
van den Bos IC; Hussain SM; Dwarkasing RS; Stoop H; Zondervan PE; Krestin GP; de Man RA
Br J Radiol; 2007 Dec; 80(960):e317-20. PubMed ID: 18065642
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Okuda S; Ogawa S; Igura T; Imai Y
J Gastroenterol; 2015 Jan; 50(1):85-94. PubMed ID: 24563123
[TBL] [Abstract][Full Text] [Related]
5. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
Kobayashi T; Aikata H; Hatooka M; Morio K; Morio R; Kan H; Fujino H; Fukuhara T; Masaki K; Ohno A; Naeshiro N; Nakahara T; Honda Y; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Takahashi S; Chayama K
Eur Radiol; 2015 Nov; 25(11):3272-81. PubMed ID: 26037713
[TBL] [Abstract][Full Text] [Related]
7. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
8. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
9. Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma: A Case Report.
Becq A; Mateescu C; Khayat D; Bouattour M
Medicine (Baltimore); 2015 Jul; 94(27):e1101. PubMed ID: 26166099
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Ye F; Liu J; Ouyang H
Medicine (Baltimore); 2015 Aug; 94(32):e1157. PubMed ID: 26266348
[TBL] [Abstract][Full Text] [Related]
11. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
12. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.
Su JS; Chen YT; Wang RC; Wu CY; Lee SW; Lee TY
World J Gastroenterol; 2013 Jan; 19(3):321-7. PubMed ID: 23372352
[TBL] [Abstract][Full Text] [Related]
15. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
17. Case Report of an Hepatoid Adenocarcinoma of the Stomach.
Gaeta R; Ugolini C; Castagna M
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):e6-8. PubMed ID: 26844385
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
[TBL] [Abstract][Full Text] [Related]
20. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
